Medicare Part D is the single most significant mental health policy initiative to have been undertaken in the last decade. We think it would be extremely helpful to have a sense of how this is actually impacting our patients and practitioners. The only way of systematically assessing the strengths and weaknesses of the new program is a survey that would get a representative sample of the experiences our patients are having.
The take-home message from these studies is that we have treatment that is effective and that the risk from depression is far greater than the risk of treatment.
What the FDA initiated was in some ways a natural experiment. This is the kind of rigorous scientific information the FDA should consider in evaluating its decisions.
Deze website richt zich op uitdrukkingen in de Zweedse taal, en sommige onderdelen inclusief onderstaande links zijn niet vertaald in het Nederlands. Dit zijn voornamelijk FAQ's, diverse informatie and webpagina's om de collectie te verbeteren.
Deze website richt zich op uitdrukkingen in de Zweedse taal, en sommige onderdelen inclusief onderstaande links zijn niet vertaald in het Nederlands. Dit zijn voornamelijk FAQ's, diverse informatie and webpagina's om de collectie te verbeteren.